Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Sorafenib Treatment Following Hematopoietic Stem Cell Transplant In Pediatric FLT3/ITD+ AML

Jessica Pollard, MD, Bill H Chang, MD, PhD, Todd Michael Cooper, Thomas Gross, MD, PhD, Sumit Gupta, MD, Phoenix A. Ho, MD, Suzanne M. McGoldrick, MD, Tanya C. Watt, MD, MSc, India Sisler, MD, Blythe Thomson, MD, Ann E Woolfrey, MD, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 3969.

https://doi.org/10.1182/blood.V122.21.3969.3969

Published: 2013

Journal Articles

Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

Betsy Hirsch, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Samir Kahwash, MD, Amy Heerema-McKenney, Richard Aplenc, MD, PhD, Lillian Sung, MD, PhD, Laura Winter, PharmD, Kathleen Glick, CCRP, Stella M. Davies, MBBS, PhD, Patti Byron, MSN, RN, Robert S. Lavey, MD, Franklin O. Smith, MD, Phoenix A. Ho, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD, Susana C. Raimondi, PhD

Blood (2013) 122 (21): 612.

https://doi.org/10.1182/blood.V122.21.612.612

Published: 2013

Journal Articles

Elevated BAALC Gene Expression Lacks Clinical Significance in Pediatric AML- A Report From the Children's Oncology Group.

Jessica A. Pollard, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Phoenix A. Ho, MD, Susana C. Raimondi, Betsy A. Hirsch, PhD, Janet Franklin, MD, MPH, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2553.

https://doi.org/10.1182/blood.V120.21.2553.2553

Published: 2012

Journal Articles

WT1 snp rs16754 Genotype Predicts Treatment Related Mortality (TRM) in African-American and Asian Pediatric AML Patients: A Report From the Children's Oncology Group

Phoenix A. Ho, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Lillian Sung, MD, PhD, Richard Aplenc, MD, PhD, Jessica A. Pollard, MD, Julia Kuhn, BA, Nyla A. Heerema, PhD, Beverly J. Lange, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 1385.

https://doi.org/10.1182/blood.V120.21.1385.1385

Published: 2012

Journal Articles

High EVI1 expression Is Associated with MLL rearrangements and Predicts Decreased Survival in Pediatric AML: A Report From the Children's Oncology Group.

Phoenix A. Ho, MD, Todd Alonzo, PhD, Robert B. Gerbing, M.A., Jessica A. Pollard, MD, Susana C. Raimondi, Betsy A. Hirsch, PhD, Todd Cooper, DO, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2530.

https://doi.org/10.1182/blood.V120.21.2530.2530

Published: 2012

Journal Articles

The Prognostic Effect of High WT1 Gene Expression in Pediatric AML Depends on WT1 SNP rs16754 Status: A Report From the Children's Oncology Group (COG)

Phoenix A. Ho, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Julia Kuhn, BA, Jessica A. Pollard, MD, Betsy A. Hirsch, PhD, Susana C. Raimondi, PhD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, Ph.D.

Blood (2011) 118 (21): 1444.

https://doi.org/10.1182/blood.V118.21.1444.1444

Published: 2011

Journal Articles

KIT Mutations Are Rare Among Elderly AML Patients: A SWOG Report

Fabiana Ostronoff, MD, Megan Othus, PhD, Phoenix A. Ho, MD, Stephen H. Petersdorf, MD, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 2510.

https://doi.org/10.1182/blood.V118.21.2510.2510

Published: 2011

Journal Articles

Prevalence and Clinical Implications of IDH2 R140 and R172 Mutations in Older Adults with AML: A Report From SWOG,

Phoenix A. Ho, MD, Megan Othus, PhD, Fabiana Ostronoff, MD, Stephen H. Petersdorf, MD, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 3516.

https://doi.org/10.1182/blood.V118.21.3516.3516

Published: 2011

Journal Articles

DNMT3A Mutations Independently Predict Poor Outcome in Older AML Patients: A SWOG Report,

Blood (2011) 118 (21): 3519.

https://doi.org/10.1182/blood.V118.21.3519.3519

Published: 2011

Journal Articles

Conventional Cytogenetics, Molecular Profiling, and Flow Cytometric Response Data Allow the Creation of a Two-Tiered Risk-Group System for Risk-Based Therapy Allocation In Childhood AML- a Report From the Children's Oncology Group

Todd A. Alonzo, PhD, Phoenix A. Ho, MD, Robert B. Gerbing, MA, Alan S. Gamis, MD, MPH, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Todd Cooper, DO, Janet Franklin, MD, MPH, Laura Pardo, Michael R. Loken, PhD, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 761.

https://doi.org/10.1182/blood.V116.21.761.761

Published: 2010

Journal Articles

TET2 SNP rs2454206 (I1762V) Correlates with Improved Survival In Pediatric Acute Myelogenous Leukemia, a Report From the Children's Oncology Group

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Phoenix A. Ho, MD, Daniel Geraghty, PhD, Beverly Lange, MD, Nyla A. Heerema, Ph.D., Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 949.

https://doi.org/10.1182/blood.V116.21.949.949

Published: 2010

Journal Articles

The WT1 synonymous SNP rs16754 Is Associated with Higher mRNA Expression and Predicts Significantly Improved Outcome In Favorable-Risk Pediatric AML: a Report From the Children's Oncology Group

Phoenix A. Ho, MD, Julia Kuhn, BA, Robert B. Gerbing, MA, Jessica A. Pollard, MD, Rong Zeng, BS, Kristen L. Miller, BS, Nyla A. Heerema, Ph.D., Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Janet Franklin, MD, MPH, Beverly Lange, MD, Alan S. Gamis, MD, MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 950.

https://doi.org/10.1182/blood.V116.21.950.950

Published: 2010

Journal Articles

CBL Mutations In Pediatric Acute Myelogenous Leukemia Are a Rare Event, a Report From the Children's Oncology Group.

Matthew A. Kutny, MD, Kristen Miller, BS, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Phoenix A. Ho, MD, Alan S. Gamis, MD, MPH, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 1659.

https://doi.org/10.1182/blood.V116.21.1659.1659

Published: 2010

Journal Articles

Identification of Post-Induction Minimal Residual Disease by Multidimensional Flow Cytometry Identifies Patients with AML at High Risk of Relapse and Poor Outcome- a Report From the Children's Oncology Group

Soheil Meshinchi, MD, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Phoenix A. Ho, MD, Alan S. Gamis, MD, MPH, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Todd Cooper, DO, Janet Franklin, MD, MPH, Laura Pardo, Michael R. Loken, PhD

Blood (2010) 116 (21): 1702.

https://doi.org/10.1182/blood.V116.21.1702.1702

Published: 2010

Journal Articles

High Expression of Neutrophil Elastase Predicts Improved Survival In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Roland B. Walter, MD, PhD, Chelsea J. Gudgeon, BS, Rhonda E. Ries, BS, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Phoenix A. Ho, MD, Alan S. Gamis, MD, MPH, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Janet Franklin, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 2762.

https://doi.org/10.1182/blood.V116.21.2762.2762

Published: 2010

Journal Articles

Association of CD33 Expression Level with Disease Risk-Group Classification and Induction Response In Pediatric AML: A Report From the Children's Oncology Group

Jessica A. Pollard, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Phoenix A. Ho, MD, Rhonda Ries, MS, Rong Zeng, BS, Kristen L. Miller, BS, Julia Kuhn, BA, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Janet Franklin, MD, MPH, Alan S. Gamis, MD, MPH, Michael R. Loken, PhD, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 2732.

https://doi.org/10.1182/blood.V116.21.2732.2732

Published: 2010

Journal Articles

Prognostic Implications of the IDH1 synonymous SNP rs11554137 In Pediatric and Adult AML: a Children's Oncology Group and Southwest Oncology Group Study

Blood (2010) 116 (21): 2737.

https://doi.org/10.1182/blood.V116.21.2737.2737

Published: 2010

NARROW

Sorafenib Treatment Following Hematopoietic Stem Cell Transplant In Pediatric FLT3/ITD+ AML

Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

Elevated BAALC Gene Expression Lacks Clinical Significance in Pediatric AML- A Report From the Children's Oncology Group.

WT1 snp rs16754 Genotype Predicts Treatment Related Mortality (TRM) in African-American and Asian Pediatric AML Patients: A Report From the Children's Oncology Group

High EVI1 expression Is Associated with MLL rearrangements and Predicts Decreased Survival in Pediatric AML: A Report From the Children's Oncology Group.

The Prognostic Effect of High WT1 Gene Expression in Pediatric AML Depends on WT1 SNP rs16754 Status: A Report From the Children's Oncology Group (COG)

KIT Mutations Are Rare Among Elderly AML Patients: A SWOG Report

Prevalence and Clinical Implications of IDH2 R140 and R172 Mutations in Older Adults with AML: A Report From SWOG,

DNMT3A Mutations Independently Predict Poor Outcome in Older AML Patients: A SWOG Report,

Conventional Cytogenetics, Molecular Profiling, and Flow Cytometric Response Data Allow the Creation of a Two-Tiered Risk-Group System for Risk-Based Therapy Allocation In Childhood AML- a Report From the Children's Oncology Group

TET2 SNP rs2454206 (I1762V) Correlates with Improved Survival In Pediatric Acute Myelogenous Leukemia, a Report From the Children's Oncology Group

The WT1 synonymous SNP rs16754 Is Associated with Higher mRNA Expression and Predicts Significantly Improved Outcome In Favorable-Risk Pediatric AML: a Report From the Children's Oncology Group

CBL Mutations In Pediatric Acute Myelogenous Leukemia Are a Rare Event, a Report From the Children's Oncology Group.

Identification of Post-Induction Minimal Residual Disease by Multidimensional Flow Cytometry Identifies Patients with AML at High Risk of Relapse and Poor Outcome- a Report From the Children's Oncology Group

High Expression of Neutrophil Elastase Predicts Improved Survival In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Association of CD33 Expression Level with Disease Risk-Group Classification and Induction Response In Pediatric AML: A Report From the Children's Oncology Group

Prognostic Implications of the IDH1 synonymous SNP rs11554137 In Pediatric and Adult AML: a Children's Oncology Group and Southwest Oncology Group Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only